Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Flamingo Therapeutics Logo
Flamingo Therapeutics Growth Score
30
CB Rank
119333
Heat Score
36
Flamingo Therapeutics is pioneering RNA-targeted therapies for oncology.
Founded
obfuscation
PrivateGrant Leuven, Vlaams-Brabant, Belgium11-50 flamingotx.com/
Biopharma
Biotechnology
Oncology
Overview

Flamingo Therapeutics
Total Funding
obfuscation
Growth Score
30
Heat Score
36

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score30
-28 pts
in past quarter
Heat Score 36
-18 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Flamingo Therapeutics

CB Rank
119333
Flamingo Therapeutics is pioneering RNA-targeted therapies for oncology.
Founded
obfuscation
PrivateGrant Leuven, Vlaams-Brabant, Belgium11-50 flamingotx.com/
Biopharma
Biotechnology
Oncology

Funding Rounds

Grant
OBF
in
obfuscation

Key People

Details

Legal Name Flamingo Therapeutics NV.
Also Known As Flamingo
Operating Status Active
Company Type For Profit
About the Company
Flamingo Therapeutics is pioneering RNA-targeted therapies for oncology.
Contact Email hello@flamingotx.com
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Growth Insight

Products & Services

Danvatirsen
An antisense oligonucleotide targeting STAT3 mRNA to inhibit tumor growth and modulate tumor immunity in oncology patients.
FLM-7523
An antisense oligonucleotide targeting the long non-coding RNA MALAT1, implicated in cancer progression and metastasis.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Flamingo Therapeutics Logo
Grant - Flamingo Therapeutics
1
obfuscation
Agentschap Innoveren & OndernemenGrant
obfuscation
Grant - Flamingo Therapeutics Logo
Grant - Flamingo Therapeutics
1
obfuscation
Agentschap Innoveren & OndernemenGrant
obfuscation
Grant - Flamingo Therapeutics Logo
Grant - Flamingo Therapeutics
1
obfuscation
Agentschap Innoveren & OndernemenGrant
obfuscation
Grant - Flamingo Therapeutics Logo
Grant - Flamingo Therapeutics
1
obfuscation
Agentschap Innoveren & OndernemenGrant
obfuscation
Grant - Flamingo Therapeutics Logo
Grant - Flamingo Therapeutics
1
obfuscation
Agentschap Innoveren & OndernemenGrant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Flamingo Therapeutics Logo
Grant - Flamingo Therapeutics
1
obfuscation
Agentschap Innoveren & OndernemenGrant
obfuscation
Grant - Flamingo Therapeutics Logo
Grant - Flamingo Therapeutics
1
obfuscation
Agentschap Innoveren & OndernemenGrant
obfuscation
Grant - Flamingo Therapeutics Logo
Grant - Flamingo Therapeutics
1
obfuscation
Agentschap Innoveren & OndernemenGrant
obfuscation
Grant - Flamingo Therapeutics Logo
Grant - Flamingo Therapeutics
1
obfuscation
Agentschap Innoveren & OndernemenGrant
obfuscation
Grant - Flamingo Therapeutics Logo
Grant - Flamingo Therapeutics
1
obfuscation
Agentschap Innoveren & OndernemenGrant

Investors

Investments

Number of Acquisitions 1

Investment Breakdown

Number of Acquisitions 1
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 1 Contacts 5

Employee Profiles

News

News and Press

News•Apr 15, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 4, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Aug 29, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jul 1, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$70.7KThis year, Flamingo Therapeutics is projected to spend $70.7K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Cyberwarfare Logo
Cyberwarfare
78
Business Insider Logo
Business Insider
77
Computer Hacking Logo
Computer Hacking
74

Active Website Tech Count

2Flamingo Therapeutics is actively using 2 technologies for its website, according to BuiltWith. These include Viewport Meta, IPhone / Mobile Compatible, and  Common Crawl.

Total IP

2Flamingo Therapeutics has registered 2 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Flamingo Therapeutics's headquarters? Flamingo Therapeutics is located in Leuven, Vlaams-Brabant, Belgium.Who invested in Flamingo Therapeutics? Flamingo Therapeutics is funded by Agentschap Innoveren & Ondernemen.When was the last funding round for Flamingo Therapeutics? Flamingo Therapeutics closed its last funding round on
obfuscation
from a Grant round.Who are Flamingo Therapeutics's competitors? Alternatives and possible competitors to Flamingo Therapeutics may include Tango Therapeutics, Onco-Innovations, and  Iambic.How much funding has Flamingo Therapeutics raised to date? Flamingo Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(8fe006b 1)
|